SDCBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.413400E-01
Normal-vs-Stage2
5.071200E-01
Normal-vs-Stage3
2.948200E-01
Normal-vs-Stage4
5.648800E-01
Stage1-vs-Stage2
4.900000E-01
Stage1-vs-Stage3
9.356400E-01
Stage1-vs-Stage4
6.379000E-01
Stage2-vs-Stage3
4.884000E-01
Stage2-vs-Stage4
9.307600E-01
Stage3-vs-Stage4
4.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.322800E-01
Normal-vs-AfricanAmerican
8.454000E-01
Normal-vs-Asian
5.391800E-01
Caucasian-vs-AfricanAmerican
3.471400E-01
Caucasian-vs-Asian
9.781800E-01
AfricanAmerican-vs-Asian
3.383000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.045600E-01
Normal-vs-Female
4.802200E-01
Male-vs-Female
3.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.247000E-01
Normal-vs-Age(41-60Yrs)
6.913400E-01
Normal-vs-Age(61-80Yrs)
3.506800E-01
Normal-vs-Age(81-100Yrs)
2.961800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.340230E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.411000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.878200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.896400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.093800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.652200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.841500E-02
Normal-vs-Daily Drinker
1.743650E-01
Normal-vs-Weekly Drinker
4.727800E-01
Normal-vs-Occasional Drinker
5.132000E-01
Normal-vs-Social Drinker
3.439400E-01
Non Drinker-vs-Daily Drinker
9.499400E-01
Non Drinker-vs-Weekly Drinker
1.799360E-01
Non Drinker-vs-Occasional Drinker
4.172000E-01
Non Drinker-vs-Social Drinker
4.543000E-01
Daily Drinker-vs-Weekly Drinker
2.737600E-01
Daily Drinker-vs-Occasional Drinker
4.564600E-01
Daily Drinker-vs-Social Drinker
5.551200E-01
Weekly Drinker-vs-Occasional Drinker
8.332200E-01
Weekly Drinker-vs-Social Drinker
6.514600E-01
Occasional Drinker-vs-Social Drinker
8.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.953200E-01
Normal-vs-Grade 2
8.765600E-01
Normal-vs-Grade 3
9.214200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.380840E-01
Grade 1-vs-Grade 3
3.709000E-01
Grade 1-vs-Grade 4
9.953200E-01
Grade 2-vs-Grade 3
3.616400E-01
Grade 2-vs-Grade 4
8.765600E-01
Grade 3-vs-Grade 4
9.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.905800E-01
Normal-vs-NonDiabetic
3.136600E-01
Diabetic-vs-NonDiabetic
7.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.824400E-01
Normal-vs-NoPancreatitis
3.806400E-01
Pancreatitis-vs-NoPancreatitis
6.999400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.577000E-01
Normal-vs-N1
5.555600E-01
N0-vs-N1
7.974200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.620600E-01
Normal-vs-TP53-NonMutant
1.788450E-01
TP53-Mutant-vs-TP53-NonMutant
1.502370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
